EDAP's lithotripter approved in Korea
This article was originally published in Clinica
Executive Summary
Sonolith i-move, a lithotripter developed by therapeutic ultrasound specialist EDAP TMS (Lyon, France), has been approved for sale by the South Korean Food and Drug Administration (KFDA). Lithotripters break up kidney or other stones using sonic shock waves. The Sonolith i-move has an infrared stereo-vision system for real-time, three-dimensional ultrasound-free localisation of urinary stones. South Korea is the second largest market in Asia for lithotripsy devices, after Japan. The device is awaiting approval in the US and Japan.